---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-043210"
form_type: "8-K"
ticker: "RMTI"
cik: "0001041024"
company_name: "ROCKWELL MEDICAL, INC."
filed_at: "2026-06-15T20:27:59+00:00"
generated_at: "2026-06-15T20:32:19.601523+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Rockwell Medical stockholders approve reverse stock split, elect directors

## Summary
- Reverse stock split amendment approved: 16,993,038 for, 6,597,036 against, 223,632 abstain.
- Class II directors Joseph Dawson and Joan Lau reelected with 9.8M and 9.9M votes for, respectively.
- Advisory vote on executive compensation passed: 8,232,918 for, 2,682,354 against, 96,595 abstain.
- Ratification of EisnerAmper LLP as auditor for 2026 approved: 22,996,530 for, 698,744 against.
- Reverse stock split intended to regain compliance with Nasdaq minimum bid price requirement.

## SEC filing metadata
- accession: 0001628280-26-043210
- form_type: 8-K
- ticker: RMTI
- cik: 0001041024
- company_name: ROCKWELL MEDICAL, INC.
- filed_at: 2026-06-15T20:27:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/rmti-20260612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-043210
- JSON: https://secwatch.observer/filing/0001628280-26-043210.json
- Plain text: https://secwatch.observer/filing/0001628280-26-043210.txt

## Key facts
- Shareholder Votes
  ROCKWELL MEDICAL, INC. shareholders approved To elect the two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified. at the 2026-06-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Proposal One: To elect the two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified. For Against Abstain Broker Non-Votes Joseph Dawson 9,812,114 869,022 330,731 12,801,839 Joan Lau, Ph.D. 9,890,379 729,615 391,873 12,801,839
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm
- Shareholder Votes
  ROCKWELL MEDICAL, INC. shareholders approved To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock. at the 2026-06-12 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Proposal Four: To approve and adopt an amendment to the Company’s Certificate of Incorporation to effect a reverse stock split of the Company’s common stock. For Against Abstain 16,993,038 6,597,036 223,632
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm
- Shareholder Votes
  ROCKWELL MEDICAL, INC. shareholders approved To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2026. at the 2026-06-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Proposal Three: To ratify the selection of EisnerAmper LLP as the Company’s independent registered public accounting firm for 2026. For Against Abstain 22,996,530 698,744 118,432
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm
- Shareholder Votes
  ROCKWELL MEDICAL, INC. shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers. at the 2026-06-12 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-12
  source text: Proposal Two: To approve, on an advisory basis, the compensation of the Company's named executive officers. For Against Abstain Broker Non-Votes 8,232,918 2,682,354 96,595 12,801,839
  evidence_url: https://www.sec.gov/Archives/edgar/data/1041024/000162828026043210/0001628280-26-043210-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.